Join the club for FREE to access the whole archive and other member benefits.

pharmaphorum

Leading online destination for healthcare and pharmaceutical industry news

pharmaphorum combines industry leading publications, strategic consulting and a content-driven stakeholder engagement agency.

We support our pharmaceutical industry clients through both the reach and reputation of our publication and our consultative and creative capabilities in marketing, medical, communications and digital innovation.

Our clients span the healthcare sector, including global pharmaceutical companies, mid-size biopharma, biotech, service providers, patient organisations / charities and healthcare providers.

We also work collaboratively with external partners, including communications / marketing agencies, physician / patient communities, technology providers, contract research organisations and many others.

Visit website: https://pharmaphorum.com/

 pharmaphorum

 pharmaphorum-media

 pharmaphorum

 pharmaphorum

Details last updated 04-Feb-2019

People at pharmaphorum

Lisa Bedwell

Senior Communications Manager, Oxford Sciences Innovation

Phil Taylor

Author at Pharmaphorum

Articles sourced from pharmaphorum

Neuralink advances brain implant to control robotic arm

Neuralink advances brain implant to control robotic arm

pharmaphorum - 28-Nov-2024

Paving the way for greater independence in patients with paralysis

RYSE invests $50 million in digital diagnostics startup

RYSE invests $50 million in digital diagnostics startup

pharmaphorum - 05-Mar-2024

Braingaze to develop apps for ADHD, autism and alzheimer's using eye-tracking technology

Isomorphic Labs partners with Eli Lilly, Novartis to use AI in drug discovery

Isomorphic Labs partners with Eli Lilly, Novartis to use AI in drug discovery

pharmaphorum - 08-Jan-2024

Their AlphaFold engine models proteins could lead to faster and more effective treatments

Smartphones are soon to be upgraded as a skin cancer diagnostic tool in UK

Smartphones are soon to be upgraded as a skin cancer diagnostic tool in UK

pharmaphorum - 29-Apr-2022

AI based-DERM could speed up diagnosis by replacing dermatology appointments

23andMe acquired virtual healthcare firm Lemonaid Health for $400M

23andMe acquired virtual healthcare firm Lemonaid Health for $400M

pharmaphorum - 25-Oct-2021

Merger to improve remote health services and offer personalised treatment plans

FDA warns robotic surgery for breast cancer is unproven and could pose health risks

FDA warns robotic surgery for breast cancer is unproven and could pose health risks

pharmaphorum - 22-Aug-2021

Prior study approval and monitoring long-term outcomes are needed to ensure patient's safety

Clinical experience in artificial heart with autoregulation of blood flow

Clinical experience in artificial heart with autoregulation of blood flow

pharmaphorum - 15-Jul-2021

New heart replacement therapy for patients with end-stage biventricular failure

New CRISPR gene-editing drug for a rare protein-misfolding disorder

New CRISPR gene-editing drug for a rare protein-misfolding disorder

pharmaphorum - 28-Jun-2021

Phase 1 trial reports, single dose of the drug cuts protein levels by 87% in ATTR amyloidosis

Nanotech nurtures unique treatment for inoperable cancers

Nanotech nurtures unique treatment for inoperable cancers

pharmaphorum - 18-Dec-2020

Innovate UK is funding specialists of nanotechnology & bioimaging to cure cancer

Microsoft AI tool fastens cancer screening tests in hospitals

Microsoft AI tool fastens cancer screening tests in hospitals

pharmaphorum - 09-Dec-2020

Project InnerEye reduces clinicians workload and improves cancer care

Clinical trials now up for Exscientia's world first AI-made drug

Clinical trials now up for Exscientia's world first AI-made drug

pharmaphorum - 30-Jan-2020

Partnering with Japan's DSP, a milestone is reached in OCD treatment

Stroke prevention device wins healthtech award

Stroke prevention device wins healthtech award

Pharmaphorum - 28-Jun-2017

Embotrap II is developed and marketed by Neuravi. Small, mesh-like construct can restore blood f...

IBM Watson to make breast cancer treatment recommendations

IBM Watson to make breast cancer treatment recommendations

pharmaphorum - 06-Jun-2017

Lessons learnt may be applied by other oncologists in future

Billionaire Jim Mellon invests in anti-ageing research firm

Billionaire Jim Mellon invests in anti-ageing research firm

pharmaphorum - 11-Apr-2017

Insilico Medicine applying big data analytics to extend healthy longevity. pursuing internal dru...